HLA-A*0201 | B2M | MAGE-A4 (KVLEHVVRV)

HLA-A*0201 | B2M | MAGE-A4 (KVLEHVVRV)

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
JS-014Exenokine-21; JS-014; AWT-008Phase 1 ClinicalAnwita Biosciences Inc
Solid tumours; Neoplasms; Lymphoma
Details
LatikafuspAMG-256Phase 1 ClinicalAmgen Inc
Solid tumours
Details